A 2′ FY-RNA motif defines an aptamer for Ebolavirus secreted protein S Shubham, J Hoinka, S Banerjee, E Swanson, JA Dillard, ... Scientific reports 8 (1), 12373, 2018 | 39 | 2018 |
Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer J Ptacek, D Zhang, L Qiu, S Kruspe, L Motlova, P Kolenko, Z Novakova, ... Nucleic Acids Research 48 (19), 11130-11145, 2020 | 25 | 2020 |
RNA inhibitors of nuclear proteins responsible for multiple organ dysfunction syndrome KT Urak, GN Blanco, S Shubham, LH Lin, JP Dassie, WH Thiel, Y Chen, ... Nature communications 10 (1), 116, 2019 | 14 | 2019 |
Aptamer-enabled uptake of small molecule ligands SL Auwardt, YJ Seo, M Ilgu, J Ray, RR Feldges, S Shubham, ... Scientific Reports 8 (1), 15712, 2018 | 3 | 2018 |
DNA aptamers for early detection of ebolavirus S Banerjee, J Hoinka, A Gosai, Z Zhu, S Devarakonda, C Geekiyanage, ... The FASEB journal 35, 2021 | 2 | 2021 |
Structurally Different Yet Functionally Similar: Aptamers Specific for the Ebola Virus Soluble Glycoprotein and GP1, 2 and Their Application in Electrochemical Sensing S Banerjee, MA Hemmat, S Shubham, A Gosai, S Devarakonda, N Jiang, ... International journal of molecular sciences 24 (5), 4627, 2023 | 1 | 2023 |
Prostate-specific Membrane Antigen (PSMA) Aptamers for Prostate Cancer Imaging and Therapy S Shubham, LH Lin, O Udofot, S Krupse, PH Giangrande | 1 | 2019 |
Aptamers for the reversible inhibition of dna polymerases SM Rupp, S Shubham, S Rose, B Cagle US Patent App. 18/057,614, 2023 | | 2023 |
Plasma Nuclease Activity is Elevated in Stage II-IV Breast Cancer S Shubham, S Kruspe, MA Curry, SD Phadke, S Sugg, JO McNamara, ... ANNALS OF SURGICAL ONCOLOGY 26, S75-S76, 2019 | | 2019 |
Nuclease-Activated Probe Technology for Cancer Detection S Shubham, S Kruspe, DD Dickey, K Urak, GN Blanco, BJ Smith, M Curry, ... MOLECULAR THERAPY 26 (5), 271-271, 2018 | | 2018 |
Aptamer-enabled uptake of small molecule ligands S Liyamali Auwardt, YJ Seo, M Ilgu, J Ray, R Feldges, M Nilsen-Hamilton, ... | | 2018 |
composition and methods for preparing capped mRNA | | |